SAG
VMD icon

SageView Advisory Group’s Viemed Healthcare VMD Stock Holding History

SageView Advisory Group’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Sell
26,627
-2,030
-7% -$20.1K 0.01% 489
2026
Q1 		$264K Buy
+28,657
New +$238K 0.01% 501

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SageView Advisory Group's VMD Position: Q2 2026 in Review

SageView Advisory Group reduced its Viemed Healthcare (VMD) stake by 7.1% in Q2 2026, selling an estimated $20.1K and leaving 26,627 shares worth $304K. The position accounts for 0.01% of the portfolio, ranked #489.

SageView Advisory Group first reported a position in VMD in Q1 2026 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • SageView Advisory Group held 26,627 shares of Viemed Healthcare worth $304K as of Q2 2026.
  • SageView Advisory Group sold 2,030 Viemed Healthcare shares in Q2 2026, an estimated $20.1K.
  • Viemed Healthcare made up 0.01% of SageView Advisory Group's portfolio in Q2 2026, its #489 holding.
  • SageView Advisory Group first reported a position in Viemed Healthcare in Q1 2026 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.